Top Abstract Purchase Related
Home
>
Node
>
Subnode

The diagnostic information value of determining tumor-associated antigen Ca-19-9 in pancreatic cancer

Samoĭlenko, V.M.; Afrikian, M.N.; Itin, A.B.

Voprosy Onkologii 35(9): 1050-1053

1989

ISSN/ISBN: 0507-3758
PMID: 2815692
Document Number: 339067
Clinical utility of radioimmunologic assessment of blood tumor-associated CA-19-9 antigen level was evaluated in 225 cases of various biliopancreatoduodenal pathology. The levels exceeded the discriminating value of 40 U/ml in 96.4% of patients with pancreatic cancer (mean - 641.7 U/ml), specifically, in those radically operated on for tumors 3 cm in diameter or larger. Application of this noninvasive method for screening for resectable pancreatic carcinoma is justified.

Document emailed within 1 workday
Secure & encrypted payments

Kawa, S.; Oguchi, H.; Homma, T. 1986: Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 3). POA (pancreatic oncofetal antigen) Nihon Rinsho. Japanese Journal of Clinical Medicine 44(8): 1821-1824
Kokhanenko, N.I.; Ignashov, A.M.; Varga, E.V.; Polkanova, M.S.; Aleshina, L.A.; Kimbarovskaia, A.A.; Osipenko, S.K.; Lebedev, E.G. 2001: Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer Voprosy Onkologii 47(3): 294-297
Harmenberg, U.; Wahren, B.; Wiechel, K.L. 1988: Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract Cancer Research 48(7): 1985-1988
Takami, H.; Hishinuma, S.; Shintoku, J.; Ogata, Y.; Abe, O. 1985: Diagnostic usefulness of serum levels of pancreatic oncofetal antigen (POA) and CA 19-9 in pancreatic cancers: monitoring of postoperative recurrences Gan no Rinsho. Japan Journal of Cancer Clinics 31(6 Suppl): 631-637
Shimano, T.; Takami, M. 1999: Pancreatic oncofetal antigen (POA), pancreatic cancer-associated antigen (PCAA) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 452-454
Tregub, A.V.; Rubtsov, I.V.; Etkin, A.F.; Iankina, Z.K. 1986: Comparison of the diagnostic value of methods for determining antibodies against the Salmonella group-B O-antigen Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 24-29
Kato, H.; Tamai, K.; Magaya, T.; Nagai, M.; Noguchi, H.; Suehiro, Y.; Torigoe, T. 1985: Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer Gan no Rinsho. Japan Journal of Cancer Clinics 31(6 Suppl): 594-599
Lan, M.S.; Hollingsworth, M.A.; Metzgar, R.S. 1990: Polypeptide core of a human pancreatic tumor mucin antigen Cancer Research 50(10): 2997-3001
Ariyama, J.; Ikenobu, H.; Kurozawa, A.; Kawai, S.; Shirota, K. 1977: Upper abdominal pain and a loss of weight and appetite (radiography of the pancreatic duct and abdominal angiography): (tumor of the pancreatic head--a tumor mainly of the uncinate process and multiple pancreatic cyst) Nihon Rinsho. Japanese Journal of Clinical Medicine 35(Suppl 2): 3106-3107; 3470-3471
Kadoshchuk, T.A.; Kanikovskiĭ, O.E. 1989: Diagnostic value of tumor markers in pancreatic pathology Klinicheskaia Khirurgiia 11: 50-54
Zou, J.P.; Shimizu, J.; Ikegame, K.; Yamamoto, N.; Ono, S.; Fujiwara, H.; Hamaoka, T. 1992: Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity Journal of Immunology 148(2): 648-655
Kim, Y.S.; Itzkowitz, S.H.; Yuan, M.; Chung, Y.; Satake, K.; Umeyama, K.; Hakomori, S. 1988: Lex and Ley antigen expression in human pancreatic cancer Cancer Research 48(2): 475-482
Shcherbak, I.G.; Potashov, L.V.; Levin, A.O.; Kulikova, A.I.; Sitkevich, R.V. 1987: Diagnostic value of determining endogenous proteinase inhibitors in cancer patients Voprosy Onkologii 33(3): 22-26
Ban, T.; Imai, K.; Yachi, A. 1989: Immunohistological and immunochemical characterization of a novel pancreatic cancer-associated antigen MUSE11 Cancer Research 49(24 Part 1): 7141-7146
Tessera, G.; Dall'Acqua, S.; De Bernardi, A.; Crivelli, F.; Gallioli, G. 1988: Tumor markers in colorectal neoplasm pathology: our experience of the diagnostic and prognostic importance of CEA antigen Chirurgia Italiana 40(6): 377-387
Thanachaiviwat, A.; Thirapakawong, C.; Leelaphatanadit, C.; Chuangsuwanich, T. 2011: Accuracy of preoperative curettage in determining tumor type and grade in endometrial cancer Journal of the Medical Association of Thailand 94(7): 766-771
Krylov, N.L.; Seleznev, I.K.; Nikitin, V.G.; Zhil'tsov, V.K. 1987: Diagnostic possibilities of radiological methods in pancreatic cancer Vestnik Rentgenologii i Radiologii 5: 22-27
Dang, C.-X.; Han, Y.; Qin, Z.-Y.; Wang, Y.-J. 2002: Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer Hepatobiliary and Pancreatic Diseases International: Hbpd Int 1(2): 302-305
Yamada, T.; Ohwada, S.; Saitoh, F.; Adachi, M.; Morishita, Y.; Hozumi, M. 1996: Induction of Ley antigen by 5-aza-2'-deoxycytidine in association with differentiation and apoptosis in human pancreatic cancer cells Anticancer Research 16(2): 735-740
Magnani, J.L.; Steplewski, Z.; Koprowski, H.; Ginsburg, V. 1983: Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin Cancer Research 43(11): 5489-5492